Explore All Access
Check if your research matches the topics covered in IN SILICO PHARMACOLOGY?
- Degree of match
- Common matching concepts
- Additional journal recommendations
IN SILICO PHARMACOLOGY : Impact Factor & More
eISSN: 2193-9616pISSN: 2193-9616
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Topics Covered on IN SILICO PHARMACOLOGY
Fusion protein
Histone deacetylase inhibitor
Influenza a
Marburg virus
Indapamide
Virtual screening
Drug toxicity
Bordetella pertussis
Drug discovery
Molecular Docking Analysis
Phytochemical
Tinospora cordifolia
Hydrochlorothiazide
Breast cancer
Bedaquiline
Coronavirus
Cardiotoxicity
Bordetella parapertussis
IN SILICO PHARMACOLOGY Journal Specifications
| Overview | |
| Publisher | SPRINGER HEIDELBERG |
| Frequency | Continuous publication |
| General Details |
View less
One subscription packed with expert publication services and AI tools to get you published
Brought to you by 
Journal Selection Service
Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.
Journal Submission Service
Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission
Bundle of AI tools for your research needs
Journal Finder, Paperpal, R Discovery, MindTheGraph and more
Planning to publish in IN SILICO PHARMACOLOGY ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in IN SILICO PHARMACOLOGY
In silico identification and in vitro validation of alpha-hederin as a potent inhibitor of Wnt/β-catenin signaling pathway in breast cancer stem cells.
- 12 Apr 2024
- In silico pharmacology
Abatement of the binding of human hexokinase II enzyme monomers by in-silico method with the design of inhibitory peptides.
- 11 Apr 2024
- In silico pharmacology
Exploring the potential of 2-arylbenzimidazole scaffolds as novel α-amylase inhibitors: QSAR, molecular docking, simulation and pharmacokinetic studies.
- 11 Apr 2024
- In silico pharmacology
Discovery of potential epidermal growth factor receptor inhibitors from black pepper for the treatment of lung cancer: an in-silico approach.
- 8 Apr 2024
- In silico pharmacology
Phytochemical identification and in silico elucidation of interactions of bioactive compounds from Citrullus lanatus with androgen receptor towards prostate cancer treatment.
- 7 Apr 2024
- In silico pharmacology
Computational inhibition of S100A8 (calgranulin A) as a potential non-invasive biomarker for rheumatoid arthritis.
- 6 Apr 2024
- In silico pharmacology
In silico identification and in vitro validation of alpha-hederin as a potent inhibitor of Wnt/β-catenin signaling pathway in breast cancer stem cells.
- 12 Apr 2024
- In silico pharmacology
Abatement of the binding of human hexokinase II enzyme monomers by in-silico method with the design of inhibitory peptides.
- 11 Apr 2024
- In silico pharmacology
Exploring the potential of 2-arylbenzimidazole scaffolds as novel α-amylase inhibitors: QSAR, molecular docking, simulation and pharmacokinetic studies.
- 11 Apr 2024
- In silico pharmacology
Discovery of potential epidermal growth factor receptor inhibitors from black pepper for the treatment of lung cancer: an in-silico approach.
- 8 Apr 2024
- In silico pharmacology
Phytochemical identification and in silico elucidation of interactions of bioactive compounds from Citrullus lanatus with androgen receptor towards prostate cancer treatment.
- 7 Apr 2024
- In silico pharmacology
Computational inhibition of S100A8 (calgranulin A) as a potential non-invasive biomarker for rheumatoid arthritis.
- 6 Apr 2024
- In silico pharmacology
Compare Similar Journals with IN SILICO PHARMACOLOGY
Select Journals to Compare with IN SILICO PHARMACOLOGY
Total journals - 9
You can select up to 3 Journals at a time
Journal of Biomolecular Structure and Dynamics
Publisher: TAYLOR & FRANCIS INC
Molecules
Publisher: MDPI
International Journal of Molecular Sciences
Publisher: MDPI
Scientific Reports
Publisher: NATURE PORTFOLIO
Bioorganic Chemistry
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCE
Frontiers in Pharmacology
Publisher: FRONTIERS MEDIA SA
Journal of Molecular Structure
Publisher: ELSEVIER
Computational Biology and Chemistry
Publisher: ELSEVIER SCI LTD
Life Sciences
Publisher: PERGAMON-ELSEVIER SCIENCE LTD
0 Journals Selected to compare with
IN SILICO PHARMACOLOGY
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on IN SILICO PHARMACOLOGY
What is the publishing frequency of IN SILICO PHARMACOLOGY? 
IN SILICO PHARMACOLOGY published with a Continuous publication frequency.
How many articles did IN SILICO PHARMACOLOGY publish last year?
In 2023, IN SILICO PHARMACOLOGY publsihed 39 articles.
What is the eISSN & pISSN for IN SILICO PHARMACOLOGY?
For IN SILICO PHARMACOLOGY, eISSN is 2193-9616 and pISSN is 2193-9616.
Who is the publisher of IN SILICO PHARMACOLOGY?
SPRINGER HEIDELBERG is the publisher of IN SILICO PHARMACOLOGY.
